73335-64-5

Basic information

• Product Name: N-Methyl-(5-bromopyrid-3-yl)methylamine
• Synonyms: N-Methyl-(5-bromopyrid-3-yl)methylamine;3-Bromo-5-[(methylamino)methyl]pyridine;3-Bromo-5-[(methylamino)methyl]pyridine 95%;1-(5-bromopyridin-3-yl)-N-methylmethanamine;(5-Bromopyridin-3-yl)-N-methylmethylamine;1-(5-broMopyridin-2-yl)-N-MethylMethanaMine;5-bromo-N-methyl-3-Pyridinemethan amine;3-Bromo-5-[(methylamino)methyl]pyridine95%
• CAS NO: 73335-64-5
• Molecular Formula: C7H9BrN2
• Molecular Weight: 201.06376
• Mol File: 73335-64-5.mol

Chemical Properties

• Boiling Point: 125 °C
• Flash Point: 106.2 °C
• Appearance: /
• Density: 1.431 g/cm³
• Vapor Pressure: 0.0199mmHg at 25°C
• Refractive Index: 1.556
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: N-Methyl-(5-bromopyrid-3-yl)methylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-Methyl-(5-bromopyrid-3-yl)methylamine(73335-64-5)
• EPA Substance Registry System: N-Methyl-(5-bromopyrid-3-yl)methylamine(73335-64-5)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 73335-64-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
N-Methyl-(5-bromopyrid-3-yl)methylamine is used as a chemical intermediate for the synthesis of various organic compounds. Its unique structure, which includes a bromo functional group and a pyridine ring, allows it to participate in a range of chemical reactions, making it a valuable component in the production of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, N-Methyl-(5-bromopyrid-3-yl)methylamine is used as a building block for the development of new drugs. Its reactivity and structural features enable the creation of complex molecules with potential therapeutic applications, contributing to the advancement of medicine and healthcare.
Used in Agrochemical Industry:
N-Methyl-(5-bromopyrid-3-yl)methylamine is also used in the agrochemical industry as a precursor for the synthesis of pesticides and other crop protection products. Its versatility in chemical reactions allows for the development of effective and targeted agrochemicals, supporting agricultural productivity and food security.
Used in Research and Development:
In research and development settings, N-Methyl-(5-bromopyrid-3-yl)methylamine is used as a reagent for exploring new chemical reactions and investigating the properties of various compounds. Its presence in the laboratory helps scientists and researchers to gain a deeper understanding of chemical processes and to develop innovative solutions in the field of chemistry.

InChI:InChI=1/C7H9BrN2/c1-9-3-6-2-7(8)5-10-4-6/h2,4-5,9H,3H2,1H3

Upstream product

• 113118-81-3 5-bromopyridine-3-carbaldehyde 
• 593-51-1 methylamine hydrochloride 

Downstream Products

• 1279030-42-0 tert-butyl {2-[methyl({5-[4-(morpholin-4-yl)phenyl]pyridin-3-yl}methyl)amino]-2-oxoethyl}carbamate 

Relevant articles and documents

INDAZOLE CONTAINING MACROCYCLES AND THERAPEUTIC USES THEREOF

Indazole macrocycle compounds of formula (I) for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole macrocycle compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states. Formula (I)

1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS

The present invention relates to the 1 H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta (GSK-3β) inhibitors and to their use in the treatment of GSK-3β-related disorders such as, for example, (i) insulin-resistance disorders; (ii) neurodegenerative diseases; (iii) mood disorders; (iv) schizophrenic disorders; (v) cancerous disorders; (vi) inflammation, (vii) osteoporosis, (viii) cardiac hypertrophy, (ix) epilepsies and (x) neuropathic pain.

NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS

The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.

NOVEL COMPOUNDS THAT MODULATE PPARγ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS

The invention relates to novel compounds corresponding to the general formula (I) below: (I) and also to the method for preparing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism),-or alternatively in cosmetic compositions.